Tirzepatide 30MG
· Lyophilised powder
Dual GIP/GLP-1 receptor agonist Tirzepatide, 30 mg lyophilised vial for research.
TIRZEPATIDE 30MG is a synthetic peptide intended exclusively for laboratory and scientific research use. Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been extensively investigated in metabolic and endocrine research examining glucose-dependent signalling, insulin and glucagon regulation, appetite and satiety pathways, gastric physiology, lipid metabolism, and overall energy homeostasis.
Product Features
- Strength: 30 mg per vial
- Compound: Tirzepatide
- Form: Lyophilized (freeze-dried) powder
- Dual GIP and GLP-1 receptor agonist
- High-purity research-grade material
- Manufactured under strict quality control standards
- Sterile, securely sealed vial
Research Applications
Tirzepatide is commonly investigated in laboratory studies involving:
- GIP and GLP-1 receptor signalling
- Glucose metabolism and glycaemic regulation
- Insulin and glucagon signalling pathways
- Appetite, satiety, and energy-balance mechanisms
- Gastric and gastrointestinal physiology
- Lipid metabolism and metabolic signalling
- Compound
- Tirzepatide 30MG
- Strength
- Form supplied
- Lyophilised powder
- Research areas
- Metabolic/GLP-1
- Storage
- Store lyophilised material refrigerated between 2–8°C (Celsius), cold and dark, protected from light and moisture.
- Batch reference
- Stated on the vial label at dispatch
- Analytical documentation
- No analytical document is currently held for this batch. Where documentation is held it is published here.
Specification
Research-use notice
All products supplied by The Peptide Kings are sold strictly for laboratory research use only. They are not medicines, not dietary supplements, and are not intended for human or veterinary consumption or administration. Information published on this website is provided for educational and scientific reference purposes only and must not be interpreted as medical advice.